Gary M. Phillips is a director of Aldeyra Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Aldeyra Therapeutics, Inc.
9 Jun 22
4
Aldeyra Therapeutics, Inc.
10 Jun 21
4
Aldeyra Therapeutics, Inc.
11 Jun 20
4
Zyla Life Sciences
21 May 20
4
Zyla Life Sciences
5 Mar 20
4
Zyla Life Sciences
20 Jun 19
3
Zyla Life Sciences
20 Jun 19
4
Aldeyra Therapeutics, Inc.
6 Jun 19
4
Aldeyra Therapeutics, Inc.
8 Jun 18
4
Mallinckrodt plc
5 Jan 18
Recent insider trades
| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 7 Jun 22 | ALDX Aldeyra Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.6 | 3,479 | 12.52 k | 3,479 |
| 7 Jun 22 | ALDX Aldeyra Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.6 | 4,639 | 16.70 k | 4,639 |
| 7 Jun 22 | ALDX Aldeyra Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.6 | 53,812 | 193.72 k | 53,812 |